Kapur Anil
SEC insider (Form 3/4/5 filer). CIK 0001730703. Director at Verastem, Inc. (VSTM) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in SAN FRANCISCO, CA.
Companies Kapur Anil has filed insider reports for
- Verastem, Inc. (VSTM): Director
- Nurix Therapeutics, Inc. (NRIX): Director
Kapur Anil
CIK: 0001730703
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 21, 2026VSTM
Verastem, Inc.
AwardDirect36K shares- - May 15, 2026NRIX
Nurix Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
31.3K shares- - May 22, 2025VSTM
Verastem, Inc.
AwardDirect8.3K shares- - May 19, 2025NRIX
Nurix Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
25K shares- - Oct 15, 2024NRIX
Nurix Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 |  VSTM Verastem, Inc. | Award | 36,000 | - | $0 | Direct |
| May 15, 2026 |  NRIX Nurix Therapeutics, Inc. | Award Director Stock Option (right to buy) | 31,250 | - | - | Direct |
| May 22, 2025 | VSTM Verastem, Inc. | Award | 8,333 | - | - | Direct |
| May 19, 2025 | NRIX Nurix Therapeutics, Inc. | Award Director Stock Option (right to buy) | 25,000 | - | - | Direct |
| Oct 15, 2024 | NRIX Nurix Therapeutics, Inc. | Award Director Stock Option (right to buy) | 50,000 | - | - | Direct |
1-5 of 5 transactions